Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The major goal is to understand why the incidence of disease is increasing in young people, for the purposes of prevention and treatment.
Darolutamide delays metastasis and reduces the risk of death in men with high-risk prostate cancer.
NKTR-214 plus Opdivo as first-line therapy had an overall response rate of 48 percent.
The entire brain processes music, giving it the power to influence mood and memory and making it a powerful therapeutic tool.
These men lived for a median of 30 months compared to 26 months for white men.
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma.
Cancer rarely appears in the fossil record—when it does, researchers jump at the chance to study it.
This Valentine’s Day, skip the date and invest your time in a testicular self-exam.
The issues and challenges associated with the disease are often quite different from those that arise in younger women.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
First-line immunotherapy combo delayed disease progression and reduced the risk of death by nearly half.
Researchers find some cancer cell lines are more sensitive to NSAID treatment.
HIV, anti-vaxxers, dengue fever and weak primary health care make the World Health Organization’s list of priorities.
Global reports show nearly 250 new cases of non-Hodgkin lymphoma in women with breast implants.
Oral care professionals are demanding that online streaming services take down the “dangerous” film at once.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.